Exosens (H8Y.DU)
- Previous Close
34.25 - Open
34.75 - Bid 36.25 x --
- Ask 36.55 x --
- Day's Range
34.75 - 36.00 - 52 Week Range
19.28 - 36.00 - Volume
0 - Avg. Volume
152 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Jul 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultra violet, short and long wave infrared, visible - near infrared, and mid wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensifiers for scientific applications; and gamma and neutron detectors, and mineral insulated extensions. The company also provides power tubes and microwave devices; and methane airborne detection solutions. It operates under the Photonis, Xenics, Telops, and El-Mul brand names. The company serves defense and surveillance, industrial research and control, life science and environment, and nuclear markets. The company was founded in 1937 and is based in Mérignac, France. Exosens operates as a subsidiary of HLD Europe S.C.A.
www.exosens.com--
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: H8Y.DU
View MorePerformance Overview: H8Y.DU
Trailing total returns as of 5/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: H8Y.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: H8Y.DU
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
7.79%
Return on Assets (ttm)
6.20%
Return on Equity (ttm)
9.96%
Revenue (ttm)
394.1M
Net Income Avi to Common (ttm)
30.7M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
150.2M
Total Debt/Equity (mrq)
63.33%
Levered Free Cash Flow (ttm)
9.57M